Chicago Partners Investment Group LLC Boosts Position in Lam Research Corporation $LRCX

Chicago Partners Investment Group LLC boosted its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 5.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,395 shares of the semiconductor company’s stock after purchasing an additional 863 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in Lam Research were worth $1,495,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Lam Research by 6.9% during the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock worth $9,389,358,000 after purchasing an additional 8,364,375 shares in the last quarter. Invesco Ltd. boosted its position in Lam Research by 2.8% during the first quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company’s stock worth $1,259,947,000 after purchasing an additional 472,636 shares in the last quarter. Nordea Investment Management AB boosted its position in Lam Research by 34.1% during the second quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock worth $1,029,210,000 after purchasing an additional 2,692,189 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Lam Research by 25.8% during the first quarter. Goldman Sachs Group Inc. now owns 9,536,708 shares of the semiconductor company’s stock worth $693,319,000 after purchasing an additional 1,953,221 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Lam Research by 4.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 8,900,506 shares of the semiconductor company’s stock worth $647,067,000 after purchasing an additional 418,077 shares in the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on LRCX shares. Cantor Fitzgerald boosted their target price on Lam Research from $155.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 14th. Deutsche Bank Aktiengesellschaft upgraded Lam Research from a “hold” rating to a “buy” rating and upped their price objective for the company from $100.00 to $150.00 in a research report on Monday, September 29th. Raymond James Financial upped their price objective on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research report on Thursday, July 31st. TD Cowen upped their price objective on Lam Research from $125.00 to $145.00 and gave the company a “buy” rating in a research report on Monday, October 13th. Finally, Needham & Company LLC upped their price objective on Lam Research from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Twenty-three research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and an average price target of $128.04.

Lam Research Stock Performance

Lam Research stock opened at $144.05 on Tuesday. The firm has a market capitalization of $181.65 billion, a P/E ratio of 34.63, a PEG ratio of 1.72 and a beta of 1.84. The stock has a fifty day moving average price of $119.90 and a 200 day moving average price of $97.75. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $153.70. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. The firm had revenue of $5.17 billion during the quarter, compared to analyst estimates of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The business’s quarterly revenue was up 33.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were paid a $0.26 dividend. The ex-dividend date was Wednesday, September 24th. This is an increase from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 annualized dividend and a yield of 0.7%. Lam Research’s payout ratio is currently 25.00%.

Insider Buying and Selling

In related news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.31% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.